Verastem, Inc.
VSTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001526119
In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Verastem, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 61 | 1 | 57 | −3 |
| Shares | 16.1M | 1 | 16.8M | +617.2K (+3.8%) |
| Value | $119.9M | $7 | $136.2M | +$16.3M (+13.6%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Verastem, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sectoral Asset Management Inc | 203,327 | $1.65M | 0.32% |
| Vontobel Holding Ltd. | 203,327 | $1.65M | 0.02% |
| Citigroup Inc | 30,075 | $244.5K | 0.00% |
| Cornercap Investment Counsel Inc | 25,274 | $205.5K | 0.04% |
| Jane Street Group, LLC | 13,696 | $111.3K | 0.00% |
| Aries Wealth Management | 13,081 | $102.8K | 0.04% |
| Dorsey Wright & Associates | 2,272 | $18.5K | 0.01% |
Sold out (10)
Institutions that held Verastem, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Baker Bros. Advisors LP | 1,336,485 | $9.94M |
| Alyeska Investment Group, L.P. | 156,762 | $1.17M |
| Ghisallo Capital Management LLC | 150,000 | $1.12M |
| Maven Securities LTD | 120,463 | $896.2K |
| Acadian Asset Management LLC | 44,319 | $328.0K |
| Rokos Capital Management LLP | 30,000 | $225.0K |
| Bridgeway Capital Management, LLC | 29,583 | $220.1K |
| Squarepoint Ops LLC | 15,293 | $113.8K |
| Beaumont Financial Advisors, LLC | 18,000 | $7.47K |
| Cutler Group LP | 41 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held Verastem, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Coastal Capital Group, Inc. | 1 | $7 |